Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.805 USD | +8.40% | -0.52% | -39.31% |
May. 14 | Transcript : ScPharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | ScPharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 39.34M | Sales 2025 * | 95.73M | Capitalization | 127M |
---|---|---|---|---|---|
Net income 2024 * | -58M | Net income 2025 * | -30M | EV / Sales 2024 * | 3.22 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.32 x |
P/E ratio 2024 * |
-2.59
x | P/E ratio 2025 * |
-5.19
x | Employees | 136 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.28% |
Latest transcript on scPharmaceuticals Inc.
1 day | +8.40% | ||
1 week | -5.82% | ||
Current month | -14.88% | ||
1 month | -15.26% | ||
3 months | -38.83% | ||
6 months | -30.82% | ||
Current year | -39.31% |
Managers | Title | Age | Since |
---|---|---|---|
John Tucker
CEO | Chief Executive Officer | 61 | 16-12-31 |
Rachael Nokes
DFI | Director of Finance/CFO | 49 | 14-08-31 |
John Mohr
CTO | Chief Tech/Sci/R&D Officer | - | 17-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 78 | 13-12-31 | |
Klaus Veitinger
BRD | Director/Board Member | 62 | 17-11-20 |
John Tucker
CEO | Chief Executive Officer | 61 | 16-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +4.49% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 3.805 | +8.40% | 276,380 |
24-05-24 | 3.51 | -0.28% | 370,196 |
24-05-23 | 3.52 | -0.56% | 621,057 |
24-05-22 | 3.54 | -7.45% | 475,205 |
24-05-21 | 3.825 | -5.32% | 246,444 |
Delayed Quote Nasdaq, May 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.31% | 127M | |
+38.59% | 727B | |
-7.89% | 354B | |
+15.66% | 328B | |
+0.24% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+4.23% | 164B | |
-1.70% | 164B |
- Stock Market
- Equities
- SCPH Stock